These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20139035)

  • 1. Accumulated immune complexes of IgE and omalizumab trap allergens in an in vitro model.
    Hsu CL; Shiung YY; Lin BL; Chang HY; Chang TW
    Int Immunopharmacol; 2010 Apr; 10(4):533-9. PubMed ID: 20139035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semi-purification of the immunoglobulin E-sweat antigen acting on mast cells and basophils in atopic dermatitis.
    Tanaka A; Tanaka T; Suzuki H; Ishii K; Kameyoshi Y; Hide M
    Exp Dermatol; 2006 Apr; 15(4):283-90. PubMed ID: 16512875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An anti-IgE monoclonal antibody that binds to IgE on CD23 but not on high-affinity IgE.Fc receptors.
    Shiung YY; Chiang CY; Chen JB; Wu PC; Hung AF; Lu DC; Pan RL; Chang TW
    Immunobiology; 2012 Jul; 217(7):676-83. PubMed ID: 22226669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils.
    Lin H; Boesel KM; Griffith DT; Prussin C; Foster B; Romero FA; Townley R; Casale TB
    J Allergy Clin Immunol; 2004 Feb; 113(2):297-302. PubMed ID: 14767445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of a monoclonal IgE-specific antibody with cell-surface IgE-Fc epsilon RI: characterization of equilibrium binding and secretory response.
    Posner RG; Paar JM; Licht A; Pecht I; Conrad DH; Hlavacek WS
    Biochemistry; 2004 Sep; 43(35):11352-60. PubMed ID: 15366945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological methods for quantifying free and total serum IgE levels in allergy patients receiving omalizumab (Xolair) therapy.
    Hamilton RG; Marcotte GV; Saini SS
    J Immunol Methods; 2005 Aug; 303(1-2):81-91. PubMed ID: 16045925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation and targeting of T-cell immune responses by IgE and IgG antibodies.
    Bheekha Escura R; Wasserbauer E; Hammerschmid F; Pearce A; Kidd P; Mudde GC
    Immunology; 1995 Nov; 86(3):343-50. PubMed ID: 8550069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of three human FcepsilonRI-transfected RBL cell-lines for identifying IgE induced degranulation utilizing peanut-allergic patient sera and peanut protein extract.
    Ladics GS; van Bilsen JH; Brouwer HM; Vogel L; Vieths S; Knippels LM
    Regul Toxicol Pharmacol; 2008 Aug; 51(3):288-94. PubMed ID: 18534732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine epitope mapping of humanized anti-IgE monoclonal antibody omalizumab.
    Zheng L; Li B; Qian W; Zhao L; Cao Z; Shi S; Gao J; Zhang D; Hou S; Dai J; Wang H; Guo Y
    Biochem Biophys Res Commun; 2008 Oct; 375(4):619-22. PubMed ID: 18725193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of allergen-specific IgE reactivity by a human Ig Fcgamma-Fcepsilon bifunctional fusion protein.
    Zhang K; Kepley CL; Terada T; Zhu D; Perez H; Saxon A
    J Allergy Clin Immunol; 2004 Aug; 114(2):321-7. PubMed ID: 15316510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Participation of the N-terminal region of Cepsilon3 in the binding of human IgE to its high-affinity receptor FcepsilonRI.
    Henry AJ; Cook JP; McDonnell JM; Mackay GA; Shi J; Sutton BJ; Gould HJ
    Biochemistry; 1997 Dec; 36(50):15568-78. PubMed ID: 9398285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of canine-human Fc IgE chimeric antibodies for the determination of the canine IgE domain of interaction with Fc epsilon RI alpha.
    Hunter MJ; Vratimos AP; Housden JE; Helm BA
    Mol Immunol; 2008 Apr; 45(8):2262-8. PubMed ID: 18187193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb.
    Wigginton SJ; Furtado PB; Armour KL; Clark MR; Robins A; Emara M; Ghaemmaghami AM; Sewell HF; Shakib F
    Clin Exp Allergy; 2008 Feb; 38(2):313-9. PubMed ID: 18070161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric immunoglobulin E reactive with tumor-associated antigen activates human Fc epsilon RI bearing cells.
    Luiten RM; Warnaar SO; Schuurman J; Pasmans SG; Latour S; Daëron M; Fleuren GJ; Litvinov SV
    Hum Antibodies; 1997; 8(4):169-80. PubMed ID: 9395919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bispecific antibody against human IgE and human FcgammaRII that inhibits antigen-induced histamine release by human mast cells and basophils.
    Tam SW; Demissie S; Thomas D; Daëron M
    Allergy; 2004 Jul; 59(7):772-80. PubMed ID: 15180766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omalizumab may not inhibit mast cell and basophil activation in vitro.
    Gericke J; Ohanyan T; Church MK; Maurer M; Metz M
    J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1832-6. PubMed ID: 25257818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of an in vitro method for the measurement of specific IgE antibody responses: the rat basophilic leukemia (RBL) cell assay.
    Dearman RJ; Skinner RA; Deakin N; Shaw D; Kimber I
    Toxicology; 2005 Jan; 206(2):195-205. PubMed ID: 15588913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omalizumab inhibits acceleration of FcεRI-mediated responsiveness of immature human mast cells by immunoglobulin E.
    Okayama Y; Kashiwakura J; Sasaki-Sakamoto T; Matsumoto K; Hashimoto N; Ohmori K; Kawakami T; Saito H; Ra C
    Ann Allergy Asthma Immunol; 2012 Mar; 108(3):188-94. PubMed ID: 22374203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases.
    D'Amato G
    Eur J Pharmacol; 2006 Mar; 533(1-3):302-7. PubMed ID: 16464445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies specific to the alpha-subunit of the mast cell's Fc epsilon R block IgE binding and trigger histamine release.
    Baniyash M; Alkalay I; Eshhar Z
    J Immunol; 1987 May; 138(9):2999-3004. PubMed ID: 2437203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.